Tomas J. Heyman serves as Executive at Akero Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Tomas J. Heyman has executed 5 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 9, 2025 involved selling 9,398 shares valued at $0.
Tomas J. Heyman currently holds 37,014 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tomas J. Heyman has been a net seller of AKRO stock. They have purchased $0 and sold $1.4M worth of shares.
Tomas J. Heyman's most recent insider trade was on Dec 9, 2025, when they sold 9,398 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 16, 2023 | AKRO | $651.0K | Option Exercise | 26,000 | $25.04 | Discretionary |
| Jun 16, 2023 | AKRO | $1.4M | Sale | 26,000 | $54.67 | Discretionary |
| May 31, 2023 | EXEL | $0 | Award | 18,176 | $N/A | Discretionary |